Medifirst Solutions 10-K 14 Apr 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Apr. 14, 2016	Jun. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	Medifirst Solutions, Inc.
Entity Central Index Key	1,522,704
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 235,688
Entity Common Stock, Shares Outstanding		41,588,879

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current Assets:
Cash	$ 156,958	$ 551
Accounts receivable, net of allowance of $0 and $500, respectively		2,255
Prepaid expenses		1,125
Inventory	$ 50,000	5,000
Total current assets	206,958	8,931
Property, Plant and Equipment, net	$ 2,159	3,822
Other Assets
Security deposit		1,065
Total other assets		1,065
Total Assets	$ 209,117	13,818
Liabilities
Bank overdraft		4,748
Accounts payable and accrued expenses	$ 123,648	19,425
Accrued expenses - officer's compensation	370,000	300,000
Due to related party	8,921	5,937
Loans payable - stockholders	24,449	42,210
Convertible notes payable	180,393	$ 5,975
Derivative Liabilities	157,617
Total current liabilities	$ 865,028	$ 378,295
Commitments & Contingencies (Note 10)
Stockholders' Equity (Deficit):
Common stock, $0.0001 par value; 1,500,000,000 shares authorized, 35,101,750 and 22,481,750 shares issued and outstanding, respectively	$ 3,510	$ 2,248
Additional paid in capital	310,183	258,755
Accumulated deficit	(969,609)	(625,485)
Total Stockholders' Deficit	(655,911)	(364,477)
Total Liabilities and Stockholders' Deficit	209,117	13,818
Series A preferred stock
Stockholders' Equity (Deficit):
Preferred stock	$ 5	$ 5
Series B Preferred Stock
Stockholders' Equity (Deficit):
Preferred stock

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Allowance on account receivable	$ 0	$ 500
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	35,101,750	22,481,750
Common stock, shares outstanding	35,101,750	22,481,750
Series A preferred stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	50,000	50,000
Preferred stock, shares outstanding	50,000	50,000
Series B Preferred Stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000	50,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Statements of Operations [Abstract]
Consulting fee revenue	$ 1,858
Product sales, net		$ 85,627
Total Revenues	$ 1,858	85,627
Cost of goods sold	5,150	50,295
Gross income	(3,292)	35,332
Expenses:
Officer's compensation	100,000	$ 100,000
Impairment of Trademark	20,000
Advertising and promotion	4,990	$ 4,354
Computer and internet	2,085	1,680
Consulting fees	30,175	151,225
Professional fees	59,086	17,531
Provision for bad debts	2,255	28,500
Rent	$ 6,483	5,274
Repairs and maintenance		526
Travel		3,924
Other	$ 19,188	15,893
Total Operating Expenses	244,262	328,907
Net loss from Operations before other income, expenses	(247,554)	(293,575)
Other income and (expenses)
Interest expense	(92,515)	$ (1,654)
Change in Fair Value -Derivatives	(4,055)
Net loss	$ (344,124)	$ (295,229)
Loss per common share - Basic and fully diluted	$ (0.01)	$ 0.02
Weighted average number of shares outstanding - Basic and fully diluted	28,646,079	18,691,886

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity - USD ($)	Total	Common Stock	Preferred Series A	Additional Paid in Capital	Accumulated Deficit
Beginning Balance at Dec. 31, 2013	$ (264,138)	$ 1,378		$ 64,740	$ (330,256)
Beginning Balance, Shares at Dec. 31, 2013		13,781,750
Issuance of common shares for services $0.05 per share	50,000	$ 100		49,900
Issuance of common shares for services $0.05 per share, Shares		1,000,000
Issuance of common shares for services $0.05 per share	25,000	$ 50		24,950
Issuance of common shares for services $0.05 per share, Shares		500,000
Issuance of common shares to repay debt at $0.0555	25,000	$ 45		24,955
Issuance of common shares to repay debt at $0.0555, Shares		450,000
Issuance of common shares for cash at $0.05 per share	10,000	$ 20		9,980
Issuance of common shares for cash at $0.05 per share, Shares		200,000
Issuance of common shares for cash at $0.05 per share	15,000	$ 30		14,970
Issuance of common shares for cash at $0.05 per share, Shares		300,000
Issuance of common shares for cash at $0.05 per share	10,000	$ 20		$ 9,980
Issuance of common shares for cash at $0.05 per share, Shares		200,000
Issuance of common shares upon partial conversion of note at $0.0001 per share	50	$ 50
Issuance of common shares upon partial conversion of note at $0.0001 per share, Shares		500,000
Issuance of common shares for services $0.05 per share	22,500	$ 45		$ 22,455
Issuance of common shares for services $0.05 per share, Shares		450,000
Issuance of common shares for services $0.13 per share	6,500	$ 5		$ 6,495
Issuance of common shares for services $0.13 per share, Shares		50,000
Issuance of common shares upon partial conversion of note at $0.0001 per share	40	$ 40
Issuance of common shares upon partial conversion of note at $0.0001 per share, Shares		400,000
Issuance of preferred shares for services $0.10 per share	5,000		$ 5	$ 4,995
Issuance of preferred shares for services $0.10 per share, Shares			50,000
Issuance of common shares for services $0.09 per share	9,000	$ 10		8,990
Issuance of common shares for services $0.09 per share, Shares		100,000
Issuance of common shares for services $0.05 per share	12,500	$ 25		12,475
Issuance of common shares for services $0.05 per share, Shares		250,000
Issuance of common shares upon partial conversion of note at $0.0001 per share	700	$ 70		630
Issuance of common shares upon partial conversion of note at $0.0001 per share, Shares		700,000
Issuance of common shares upon partial conversion of note at $0.0001 per share	1,000	$ 100		900
Issuance of common shares upon partial conversion of note at $0.0001 per share, Shares		1,000,000
Issuance of common shares upon partial conversion of note at $0.0001 per share	1,100	$ 110		990
Issuance of common shares upon partial conversion of note at $0.0001 per share, Shares		1,100,000
Issuance of common shares upon partial conversion of note at $0.0001 per share	1,500	$ 150		$ 1,350
Issuance of common shares upon partial conversion of note at $0.0001 per share, Shares		1,500,000
Net loss	(295,229)				$ (295,229)
Ending Balance at Dec. 31, 2014	(364,477)	$ 2,248	$ 5	$ 258,755	$ (625,485)
Ending Balance, Shares at Dec. 31, 2014		22,481,750	2,248
Issuance of common shares upon partial conversion of note at $0.0001 per share	$ 2,000	$ 200		1,800
Issuance of common shares upon partial conversion of note at $0.0001 per share, Shares		2,000,000
Cancellation of common shares		$ (50)		50
Cancellation of common shares, Shares		(500,000)
Issuance of common shares upon partial conversion of note at $0.0005 per share	$ 400	$ 80		320
Issuance of common shares upon partial conversion of note at $0.0005 per share, Shares		800,000
Contribution to additional paid in capital	1,050			1,050
Issuance of common shares upon partial conversion of note at $0.0005 per share	150	$ 30		120
Issuance of common shares upon partial conversion of note at $0.0005 per share, Shares		300,000
Issuance of common shares upon partial conversion of note at $0.0005 per share	500	$ 100		400
Issuance of common shares upon partial conversion of note at $0.0005 per share, Shares		1,000,000
Issuance of common shares upon partial conversion of note at $0.0005 per share	400	$ 100		400
Issuance of common shares upon partial conversion of note at $0.0005 per share, Shares		1,000,000
Contribution to additional paid in capital	1,575			1,575
Issuance of common shares upon partial conversion of note at $0.0005 per share	1,900	$ 380		1,520
Issuance of common shares upon partial conversion of note at $0.0005 per share, Shares		3,800,000
Issuance of common shares to acquire subsidiary at $0.015 per share	20	$ 2		18
Issuance of common shares to acquire subsidiary at $0.015 per share, Shares		20,000
Issuance of common shares for services $0.01 per share	35,000	$ 350		34,650
Issuance of common shares for services $0.01 per share, Shares		3,500,000
Contribution to additional paid in capital	1,575			1,575
Issuance of common shares to investor $.01 per share	20	$ 20
Issuance of common shares to investor $.01 per share, Shares		200,000
Issuance of common shares for services $0.01 per share	5,000	$ 50		4,950
Issuance of common shares for services $0.01 per share, Shares		500,000
Additional paid in capital on debt discount related to intrinsic beneficial conversion feature	3,000			$ 3,000
Net loss	(344,124)				$ (344,124)
Ending Balance at Dec. 31, 2015	$ (655,911)	$ 3,510	$ 5	$ 310,183	$ (969,609)
Ending Balance, Shares at Dec. 31, 2015		35,101,750	50,000

Consolidated Statement of Stoc6

Consolidated Statement of Stockholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Issuance of common shares for cash, share price		$ 0.05
Issuance of common shares for cash, share price one		0.05
Issuance of common shares for cash, share price two		0.05
Issuance of common shares to repay debt share price		0.0555
Issuance of common shares upon partial conversion of note, share price	$ 0.0001	0.0001
Issuance of common shares upon partial conversion of note, share price one	0.0005	0.0001
Issuance of common shares upon partial conversion of note, share price two	0.0005	0.0001
Issuance of common shares upon partial conversion of note, share price three	0.0005	0.0001
Issuance of common shares upon partial conversion of note, share price four	0.0005	0.0001
Issuance of common shares upon partial conversion of note, share price five	0.0005	0.0001
Issuance of common shares to acquire subsidiary, share price	0.015
Common Stock [Member]
Issuance of shares for services, share price	0.01	0.05
Issuance of shares for services, share price one	0.01	0.05
Issuance of shares for services, share price two		0.05
Issuance of shares for services, share price three		0.13
Issuance of shares for services, share price four		0.09
Issuance of shares for services, share price five		0.05
Issuance of shares to investor, Share price	$ 0.01
Preferred Stock [Member]
Issuance of shares for services, share price four		$ 0.10

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net loss	$ (344,124)	$ (295,229)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation expense	1,663	3,933
Provision for doubtful accounts	$ 2,255	28,500
Accounts receivable		(2,755)
Prepaid expenses	$ 1,125	1,375
Inventory	(45,000)	2,500
Security deposit	1,065	(800)
Accounts payable and accrued expenses	174,243	87,467
Interest/excess of fair value of shares issued to repay loans	5,450	$ 30,290
Notes payable derivatives	157,617
Due to related party	2,984	$ 5,937
Stockholder's loan	(17,761)	355
Common stock issued for services	$ 40,000	125,500
Preferred stock issued for services		5,000
Net cash used by operating activities	$ (20,483)	(35,927)
Cash flows from investing activities:
Purchase of equipment		(2,556)
Net cash used by investing activities		(2,556)
Cash flows from financing activities:
Bank overdraft	$ (4,748)	3,104
Proceeds from issuance of common stock	20	$ 35,000
Contribution of additional paid in capital	7,200
Proceeds from issuance of convertible debt	$ 174,418
Payments and settlements on convertible debt		$ 2,790
Net cash provided by financing activities	$ 176,890	35,314
Net increase in cash	156,407	(3,169)
Cash at beginning of period	551	3,720
Cash at end of period	156,958	551
Cash paid during the period for:
Interest	759	805
Income taxes	$ 550	$ 800

Nature of Operations and Summar

Nature of Operations and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Note 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization Medifirst Solutions, Inc. ("MSI" or the "Company") was incorporated in Nevada in November 2010. The Company has not generated significant sales to date. The Company intends to have a diverse product line of consumer products. Since inception, the Company has been engaged in business planning activities, including researching the industry, identifying target markets for the Company's products, developing the Company's models and financial forecasts, performing due diligence regarding potential geographic locations most suitable for establishing the Company's offices and identifying future sources of capital. At the present time, the Company is building products and affiliations in and related to the cosmetic healthcare industry. Pursuant to a sale and purchase agreement dated August 19, 2015 between the Company and the Company's president, the Company acquired 100% of the equity interests in Medical Lasers Manufacturer, Inc. ("MLM") with the total purchase price of 20,000 shares of the Company's common stock at $0.001 per share (or $20). The fair value of the acquired entity was $20. The transaction was considered as a business acquisition and accordingly the acquisition method of accounting has been applied. MLM had no assets at the date of the business combination. The Consolidated financial statements include the accounts of MSI and its only wholly owned subsidiary, MLM. All material intercompany balances and transactions have been eliminated in consolidation. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology. Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal recurring nature. The Company has adopted Accounting Standards Update 2014-10, Development Stage Entities (Topic 915), Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. Revenue Recognition In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company's historical return experience. Revenue is presented net of returns. Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management's estimate of the amount of receivables that will actually be collected. Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value. Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years. Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset. In August 2015, the Company's wholly-owned subsidiary MLM, acquired a trademark for $20,000. Due to the uncertainty of future cash flows from the trademark, management has deemed it to be impaired and recorded an impairment expense of $20,000 in September 2015. Debt Issues Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed. For December 31, 2015 and retroactively, the Company has early-adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See Note 7 to Consolidated Financial Statements). Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt. Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments; Statement of Financial Accounting Standard ASC 815 Accounting for Derivative Instruments and Hedging Activities; and Emerging Issues Task Force (“EITF”) Issue No. 00–19 and EITF 07–05. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. Use of Estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values. Segment Information The Company follows Accounting Standards Codification ("ASC") 280, "Segment Reporting". The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations. Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses, common stock equivalents, if any, are not considered, as their effect would be anti-dilutive. Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities, and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of December 31, 2015, and does not expect this to change significantly over the next 12 months. Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At December 31, 2015, the Company had $156,959 in cash equivalents. Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company for the fiscal year beginning June 1, 2017. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. On January 05, 2016, the FASB completed its Classification and Measurement of Financial Instruments project by issuing ASU No. 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance improves certain aspects of recognition, measurement, presentation and disclosure of financial instruments. For public business entities, the new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. " In November 2015, FASB issued ASU 2015-17 - Income Taxes (Topic 740) Balance Sheet Classification of Deferred Taxes which simplifies the presentation of deferred income taxes. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In February 2015, FASB issued ASU 2015-02 Consolidation (Topic 810) Amendments to the Consolidation Analysis. The amendments in this Update affect reporting entities that are required to evaluate whether they should consolidate certain legal entities. All legal entities are subject to reevaluation under the revised consolidation model. The amendments in this Update are effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material.

Property, Plant and Equipment (

Property, Plant and Equipment (Net)	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment (Net) [Abstract]
PROPERTY, PLANT AND EQUIPMENT (NET)	Note 2. PROPERTY, PLANT AND EQUIPMENT (NET) Equipment is recorded at cost and consisted of the following at December 31, 2015 and 2014: December 31, 2015 2014 Computer equipment $ 8,314 $ 8,314 Less: accumulated depreciation (6,155 ) (4,492 ) $ 2,159 $ 3,822 Depreciation expense was $1,663 and $3,933 for the years ended December 31, 2015 and 2014, respectively.

Due to Related Party

Due to Related Party	12 Months Ended
	Dec. 31, 2015
Due to Related Party [Abstract]
DUE TO RELATED PARTY	Note 3. DUE TO RELATED PARTY The Company was indebted to a related party through common management in the amount of $8,921 at December 31, 2015 and December 31, 2014,respectively. The loan bears no interest and is payable on demand.

Loans Payable - Stockholders

Loans Payable - Stockholders	12 Months Ended
	Dec. 31, 2015
Loans Payable - Stockholders [Abstract]
LOANS PAYABLE - STOCKHOLDERS	Note 4. LOANS PAYABLE - STOCKHOLDERS During the periods ended December 31, 2015 and 2014 a stockholder of the Company advanced the Company $39,355 and $31,665 respectively. The loan had a balance of $20,899 and $42,210 at December 31, 2015 and December 31, 2014, respectively. The loan bears no interest and is payable on demand. At December 31, 2015 and December 31, 2014, the Company was indebted to a stockholder in the amount of $1,950 and $5,000, respectively. The loan has an interest rate of 20%. Principal and accrued interest were due and payable on July 2, 2012. In December 2012, the Company issued a promissory note to a stockholder in the amount of $5,000 with interest at 10% per annum. Principal and interest were due and payable on June 2, 2013. In April 2014, the note was amended to provide the note holder with the option to convert the note to the Company's common stock at $0.0001 per share. Subsequently, in 2014, in a private transactions, the note holder transferred $2,500 of note principal to third parties and the new holders converted their holdings into 2,500,000 shares of the Company's common stock. During 2015, the original note holder transferred an additional $2,400 of note principal to third parties who converted their holdings into 2,400,000 shares of the Company's common stock. At December 31, 2015 and December 31, 2014, the loan had balance was $100 and $4,000, respectively. At December 31, 2015 and December 31, 2014, the Company was indebted to a stockholder in the amount of $1,500 and $1,500, respectively. The loan has an interest rate of 26.7%. Principal and accrued interest were due and payable on January 1, 2014.

6% Convertible Notes Payable

6% Convertible Notes Payable	12 Months Ended
	Dec. 31, 2015
6% Convertible Notes Payable [Member]
Short-term Debt [Line Items]
CONVERTIBLE NOTES PAYABLE	Note 5. 6% CONVERTIBLE NOTES PAYABLE In March 2011, the Company issued $800 aggregate principal amount of 6% convertible notes due in January 2012. Interest on the notes accrue at the rate of 6% per annum and are payable when the notes mature. The notes matured prior to conversion but have not been repaid. Interest continues to accrue at the rate of 6% per annum. The holder of one of the notes converted $110 of note principal into 1,100,000 shares of common stock as follows: Principal Amount Conversion Shares Date of Conversion Converted Rate Received June 2013 $ 70 $ 0.0001 700,000 August 2013 $ 40 $ 0.0001 400,000 In August 2013, in a private transaction, the same note holder transferred $330 of the remaining note principal plus $55 in accrued interest to a third party. In August 2013, in a private transaction, the new note holder transferred $5 of the remaining note principal to a third party who then converted the note into 50,000 shares of common stock. In September 2013, the new note holder converted $100 of note principal into 1,000,000 shares of common stock. In September 2013, in a private transaction, the new note holder transferred $35 of the remaining note principal to a third party who then converted the note into 350,000 shares of common stock. In November and December 2013, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received November 2013 $ 40 $ 0.0001 400,000 December 2013 $ 50 $ 0.0001 500,000 In March and April 2014, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received March 2014 $ 50 $ 0.0001 500,000 April 2014 $ 40 $ 0.0001 400,000 Subsequent to these conversions there remains $125 in note principal. In July 2013, the holder of the second note converted $240 of note principal into 400,000 shares of the Company's common stock at $0.0006 per share. At December 31, 2015 and 2014, the note had a remaining principal balance of $60 and $60, respectively. At any time on or after the maturity date, the holders of the notes, have the option of converting any of the unpaid principal and interest into the Company's common stock. The notes plus any accrued but unpaid interest are convertible at the rate of $0.0001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 3,506,665 shares at December 31, 2015. In May 2012, the Company issued a $25,000 6% per annum note that matured in November 2012. In December 2012 the note was amended to be a convertible note. Interest on the note accrues interest at 6% per annum and is payable when the note matures. The holder of the $25,000 note had the option of converting it at any time prior to maturity. The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock. The holder of the note converted $1,010 of note principal into 1,010,000 shares of common stock as follows: The holder of the note converted $1,010 of note principal into 1,010,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received December 2012 $ 150 $ 0.001 $ 150,000 January 2013 $ 660 $ 0.001 $ 660,000 March 2013 $ 200 $ 0.001 $ 200,000 In July 2013, the Company retired $14,000 of note principal in payment for consulting services provided to the note holder. In July 2013, the note holder converted $300 of note principal into 300,000 shares of the Company's common stock. In July 2013, in a private transaction, the note holder transferred the remaining note principal balance of $9,690 to a third party. In August 2013, in a private transaction, the new note holder transferred $4,475 of principal to a stockholder of the company. In October 2013, the note holder converted $400 of note principal into 400,000 shares of the Company's common stock at $0.001 per share. In October 2014, the note holder converted $1,100 of note principal into 1,100,000 of the Company's common stock. At December 31, 2015, the remaining principal on this portion of the note is $3,715. The note holder has the option of converting the balance at any time with the approval of the Board of Directors. The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 3,506,665 shares at December 31, 2015. In August 2013, the note holder/stockholder converted $700 of note principal into 700,000 shares of the Company's common stock at $0.001 per share. In October 2013, in a private transaction, this note holder transferred $1,000 of note principal to a third party of which $700 was converted into 700,000 shares in June 2014. The remaining principal balance on this portion of the note at September 30, 2015 is $2,075. The note holder has the option of converting the balance at any time with the approval of the Board of Directors. The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 3,506,665 shares at December 31, 2015. In April 2015, the Company issued a $3,000 8% per annum note that matures in October 2015. The holder of the note has the right to convert the principal into shares of the Company's common stock at any time 180 days after the closing date at $0.0001 per share. Interest on the note accrues interest at 8% per annum and is payable when the note matures.

8% Convertible Note Payable

8% Convertible Note Payable	12 Months Ended
	Dec. 31, 2015
8% Convertible Notes Payable [Member]
Short-term Debt [Line Items]
CONVERTIBLE NOTES PAYABLE	In July 2015, the Company issued a convertible note payable in the principal amount of $59,000. The note matures in March 2016 and bears interest at 8%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date. In August 2015, the Company issued a convertible note payable in the principal amount of $38,000. The note matures in March 2016 and bears interest at 8%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date. On October 8, 2015, the Company issued a convertible note payable in the principal amount of $31,000 with an Original Issue Discount of $1,500. The note matures on October 8, 2016 and bears interest at 8%. The note holder has has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date.

5% Convertible Notes Payables

5% Convertible Notes Payables	12 Months Ended
	Dec. 31, 2015
5% CONVERTIBLE NOTES PAYABLE
Short-term Debt [Line Items]
CONVERTIBLE NOTES PAYABLE	Note 7. 5% CONVERTIBLE NOTES PAYABLE In June 2015, the Company issued a convertible note payable in the principal amount of $100,000. The note matures in December 2015 and bears interest at 5%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date. On October 15, 2015 the Company issued a convertible note payable in the principal amount of $35,000 with an Original Issue Discount of $5,000. The note matures on October 15, 2016 and bears interest at 5%. The note holder has has the right at any time on or after the day that is six months from October 15, 2015 to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 55% of the lowest market trading prices during the 20 days prior to the conversion date. The Company’s convertible notes payable and the related derivative liabilities, derivative discount, deferred financing costs and original-issue discount are presented in the financial statements at December 31, 2015 as follows: Schedule of all Convertible Notes Payable at December 31, 2015 Total Original Deferred Convertible Face Issue Derivative Financing Notes Derivative Debt Amount Discount Discount Costs Payable Liability Note Payable - BS $ 125 $ 125 Note Payable - SF 60 60 Note Payable - MC #1 2,075 2,075 Note Payable - NW 3,715 3,715 Note Payable - MC #2 3,000 3,000 Debenture Payable (5%) - B 100,000 100,000 35,176 Convertible Note Payable - CB (5%) 35,000 (3,945 ) (789 ) 30,266 Convertible Note Payable - LGC (8%) 31,000 (1,155 ) (26,314 ) (3,657 ) (126 ) 56,366 Convertible Notes Payable- VV (8%) #1 59,000 (52,321 ) (1,729 ) 4,950 66,075 Convertible Notes Payable- VV (8%) #2 38,000 (1,673 ) 36,327 $ 271,975 $ (5,100 ) $ (78,635 ) $ (7,847 ) $ 180,393 $ 157,617 As of December 31, 2015, the convertible notes payable can be converted into approximately 86,385,000 shares of common stock.

Derivatives and Fair Value Inst

Derivatives and Fair Value Instruments	12 Months Ended
	Dec. 31, 2015
Derivatives and Fair Value Instruments [Abstract]
DERIVATIVES AND FAIR VALUE INSTRUMENTS	Note 8. DERIVATIVES AND FAIR VALUE INSTRUMENTS The Company applied paragraph 815-10-05-4 of the FASB Accounting Standards Codification to the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015. Based on the guidance in paragraph 815-10-05-4 of the FASB Accounting Standards Codification the Company concluded these instruments were required to be accounted for as derivatives on issuance date. The Company records the fair value of the Convertible Notes Payable and certain warrants that are classified as derivatives on issuance date and the fair value changes on each reporting date reflected in the consolidated statements of operations as “Gain (loss) on derivative liabilities.” These derivative instruments are not designated as hedging instruments under paragraph 815-10-05-4 of the FASB Accounting Standards Codification and are disclosed on the balance sheet under Derivative Liabilities. The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its fin+A390ancial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepayments and other current assets, accounts payable, and accrued expenses, approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015, for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. We have valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a valuation consultant, for which management understands the methodologies. These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of issuance and December 31, 2015. The primary assumptions include: projected annual volatility of 151.4%-153.3%; the follow-on securities purchase option; the conversion feature as a percentage of Market; automatic/conditional conversions; market price trigger events. As of December 31, 2015 the Company’s derivative financial instruments included: 1) Embedded derivatives associated with certain of the Company’s unsecured convertible notes payable. The Company’s 5 % convertible notes payable and 8% convertible notes payable issued to two unrelated investors is a hybrid instrument, which warrants separate accounting as a derivative instrument. The embedded derivative feature has been bifurcated from the debt host contract, referred to as the Derivative Liability, which resulted in a reduction of the initial carrying amount (as unamortized discount) of the Convertible Notes Payable. The unamortized discount is amortized to interest expense using the effective interest method over the life of the Notes. The embedded derivative feature includes the conversion feature within the notes and an early redemption option. The compound embedded derivatives within the convertible notes have been recorded at fair value at the date of issuance; and are marked-to-market each reporting period with changes in fair value recorded to the Company’s statement of operations as Change in fair value of derivative liabilities. The 5% Convertible Note Payable and the 8% Convertible Notes Payable are valued at 12/31/15. The following assumptions were used for the valuation of the embedded derivative: - The stock price of $0.010 to $0.0073 in this period (variable conversion price) would fluctuate with the Company projected volatility; - An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%; - Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%; - Capital raising events (a single financing at 1 months from the valuation date) are a factor for the 5% Convertible Note. The full reset events projected to occur based on future stock issuance (single event) resulting in a reset exercise price. - The monthly trading volume would average $258,000 and would increase at 1% per month - The variable conversion price of 50% to 55% over 3 to 10 trading days would have effective rates of 44.12% to 51.14%; - The Note Holders would automatically convert the notes with variable conversion prices and full ratchet resets if the registration was effective and not in default; - The projected annual volatility for each valuation period was based on the historical volatility of 17 comparable companies: 10/8/2015 154 % 12/9/2015 153 % 12/22/2015 152 % 12/31/2015 151 % The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuation. The Company’s convertible notes payable and the related derivative liabilities, derivative discount and original-issue discount are presented in the financial statements at December 31, 2015 as follows: Convertible Note Derivitive Treatment Date Maturity Date Principal Note Amount Original Mark to Market Derivative Value at December 31, 2015 8 % Convertible Note Payable-issued 10/8/2015 10/8/15 10/8/16 $ 31,000 $ 58,779 $ (2,413 ) $ 56,366 5 % Convertible Note Payable-issued 6/12/15 12/9/15 12/12/15 100,000 37,827 (2,651 ) 35,176 8 % Convertible Note Payable-issued 6/25/15 12/22/15 3/30/16 59,000 56,956 9,119 66,075 $ 190,000 $ 153,562 $ 4,055 $ 157,617

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2015
Stockholders' Equity [Abstract]
STOCKHOLDERS' EQUITY	Note 9. STOCKHOLDERS' EQUITY The Company has authorized 1,500,000,000 shares of common stock with a par value of $0.0001 per share. There were 35,101,750 and 22,481,750 shares of common stock issued and outstanding at December 31, 2015 and December 31, 2014, respectively. The Company has authorized 1,000,000 shares of Series A preferred stock with a par value of $0.0001 per share. At December 31, 2015 and December 31, 2014, 50,000 shares of Series A preferred stock were issued and outstanding. The preferred stock has preferential voting rights of 2,000 votes per outstanding share. The Company has authorized 50,000 shares of Series B convertible preferred stock with a par value of $0.0001 per share. At December 31, 2015 and December 31, 2014, none of the shares of Series B preferred stock were issued and outstanding. The Series B preferred stock has no voting rights. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock. During the quarter ended March 31, 2015, the Company issued 2,000,000 shares of common stock at $0.001 per share as partial conversion of notes. During the quarter ended March 31, 2015, the Company issued 800,000 shares of common stock at $0.0005 per share as partial conversion of notes. During the quarter ended March 31, 2015, a stockholder of the Company returned 500,000 shares of common stock to the Company. During the quarter ended June 30, 2015, the Company issued 2,300,000 shares of common stock at $0.0005 per share as partial conversion of notes. During the quarter ended September 30, 2015, the Company issued 3,800,000 shares of common stock at $0.0005 per share as partial conversion of notes. During the quarter ended September 30, 2015, the Company issued 20,000 shares of common stock at $0.015 per share as to acquire 100% of the outstanding shares of the Company's subsidiary. During the quarter ended September 30, 2015, the Company issued 3,000,000 shares of common stock at $0.01 per share as Officer's compensation. During the quarter ended September 30, 2015, the Company issued 500,000 shares of common stock at $0.01 per share for services provided to the Company. During the quarter ended December 31, 2015, the Company issued 500,000 shares of common stock at $0.01 per share for services provided to the Company. During the quarter ended December 31, 2015, the Company issued 200,000 shares of common stock at $0.01 per share to an investor.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2015
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	Note 10. COMMITMENTS AND CONTINGENCIES The Company currently rents its offices on a month to month basis from the Company's President and stockholder for $525 per month. Rent expense for the year ended December 31, 2015 and 2014, totaled $6,500 and $5,274, respectively and was respectively, a portion of which was forgiven and converted to additional paid-in capital.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Income Taxes [Abstract]
INCOME TAXES	Note 11. INCOME TAXES The Company's deferred tax asset consists primarily of carryforward net operating losses (NOLs). The Company believes that, at this time, it is more likely than not that the benefit of the NOLs will not be realized and has therefore recorded a full valuation allowance as follows: December 31, 2015 December 31, 2014 Net operating loss carryforward $ 413,000 $ 268,000 Valuation allowance (413,000 ) (268,000 ) Deferred tax asset, net $ - $ - The income tax benefit differs from the amount computed by applying the statutory federal and state income tax rates to the loss before income taxes. The sources and tax effects of the differences are as follows: December 31, 2015 December 31, 2014 Statutory federal income tax rate 34 % 34 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (43 )% (43 )% Effective income tax rate 0 % 0 % As of December 31, 2015, the Company has a net operating loss carryforward of approximately $961,000 to reduce future federal and state taxable income through 2035. The Company paid $550 and $800 for state taxes for the year ended December 31, 2015 and 2014 respectively. These amounts are included in "Other" Expenses in the Consolidated Statement of Operations. The Company currently has no federal or state tax examinations in progress, nor has it had any federal or state examinations since its inception. All of the Company's open tax years beginning in tax year 2013 are subject to federal and state tax examinations.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2015
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	Note 12. RELATED PARTY TRANSACTIONS In August 2015, the Company acquired 100% of the issued and outstanding common stock of Medical Lasers Manufacturer, Inc. ("MLM") from a stockholder and officer of the Company for 20,000 common shares which were valued at $0.015 per share. All intercompany transactions were eliminated during consolidation. As more fully described in Note 4 to the Consolidated Financial Statements, the Company owed the following amounts to related parties as of December 31: 2015 2014 Due to Related Party $ 8,921 $ 5,937 Due to Officer/Stockholder 20,898 33,210 Due to other Stockholders 3,550 9,000 Total Related Party Obligations $ 33,369 $ 48,147 The company has entered into an employment agreement with its Chief Executive Officer (CEO) for the five year period beginning January 1, 2012. The agreement provides for base compensation, annual bonus, benefits, vacation and reimbursements. Under this agreement, the base compensation of the Company's CEO is $100,000 per annum and has been accrued for the years ended December 13, 2015 and 2014. Accrued compensation in the amount of $30,000 was converted to shares of common stock during 2015. In May 2014, in consideration for his services, the Company issued Bruce Schoengood, its Chief Executive Officer, 50,000 shares of its Series A Preferred Stock, which shares provide for a voting right of 2,000 per share, are not convertible and are not entitled to dividends or liquidation preferences or distributions. In August 2015, MLM acquired a trademark from the son of the Company’s President for $20,000 due 90 days from the date of acquisition. As of December 31, 2015, no payment has been made on this liability. Due to the uncertainty of future cash flows from the trademark management has deemed it to be impaired and has recorded an impairment expense of $20,000 at September 30, 2015. In August 2015, subsequent to the date the Company acquired MLM, MLM purchased $50,000 in inventory from the son of the Company's President. The inventory consisted of 20 hand-held laser devices. As of December 31, 2015, no payment has been made on this liability.

Basis of Reporting - Going Conc

Basis of Reporting - Going Concern	12 Months Ended
	Dec. 31, 2015
Basis of Reporting - Going Concern [Abstract]
BASIS OF REPORTING - GOING CONCERN	Note 13. BASIS OF REPORTING – GOING CONCERN The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses from inception of approximately $964,000, which, among other factors, raises substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon management's plans to raise additional capital from the sale of stock and receive additional loans from related parties. The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	Note 14. SUBSEQUENT EVENTS On January 7, 2016, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”) for the sale of convertible redeemable notes in aggregate principal amount of $251,803. On January 7, 2016, the Company and the Investor conducted the first closing under the Purchase Agreement, pursuant to which the Company issued to the Investor (i) a convertible redeemable note in principal amount of $105,000 containing an original issue discount of $20,000 (the “$105K Note”); and (ii) a convertible redeemable note in principal amount of $50,000 (the “$50K Note” and together with the $105K Note, the “Notes”). In consideration for the issuance of the $105K Note, on January 13, 2016, the Company received net proceeds (after deducting the original issue discount and legal fees) in the amount of $75,696.69. In consideration for the issuance of the $50K Note, the Investor issued to the Company a $50,000 fully-collateralized secured promissory note (the “Investor Note”), pursuant to which the Investor agreed to pay the Company $50,000 on or before April 30, 2016. Under the Purchase Agreement, on March 15, 2016, the Company and the Investor conducted an additional closing for the sale and purchase of additional notes having the same terms as the Notes in principal amounts equal to $50,000 and $46,803, respectively. In consideration for the issuance of the $50,000 Note, on March 15, 2016, the Company received gross proceeds of $50,000. In consideration for the issuance of the $46,803 note, the Investor issued to the Company a $46,803 fully-collateralized secured promissory note, pursuant to which the Investor agreed to pay the Company $46,803 on or before June 15, 2016. All notes issued pursuant to the Purchase Agreement bear interest at the rate of 8% per annum. Subject to a beneficial ownership limitation equal to 9.99%, principal and interest on all the notes issued pursuant to the Purchase Agreement convertible into shares of the Company’s common stock at a conversion price equal to 55% of the lowest trading price of Common Stock during the 20 trading day period prior to conversion. On January 7, 2016, the Company issued to the Investor a convertible redeemable replacement note in principal amount of $61,508.71 (the “$61K Replacement Note”). The issuance of the $61K Replacement Note was made in connection with the Investor’s purchase of a convertible promissory note in principal amount of $59,000 that was originally issued by the Company on June 25, 2015 (the “$61K Original Note”). The $61,508.71 principal amount of the $61K Replacement Note reflected the principal and accrued interest under the $61K Original Note. The $61K Replacement Note, which is due on January 7, 2017, may not be prepaid but otherwise contains identical provisions to that of the Notes. On February 29, 2016, the Company issued to the Investor a convertible redeemable replacement note in principal amount of $39,557.48 (the “Replacement Note”). The issuance of the Replacement Note was made in connection with the Investor’s purchase of a convertible promissory note in principal amount of $38,000 that was originally issued by the Company on August 31, 2015 (the “Original Note”). The $39,557.48 principal amount of the Replacement Note reflected the principal and accrued interest under the Original Note. The Replacement Note, which is due on February 28, 2017, may not be prepaid but otherwise contains identical provisions to that of the Notes. In February 2016, one shareholder converted 3,400 shares of Series B Preferred Stock into 1,700,000 shares of common stock. The conversion of 3,400 shares of Series B Preferred Stock was a partial conversion of the 10,000 shares of the Series B Preferred Stock it issued in satisfaction of the obligation to issue such shares to the seller of $50,000 of inventory the Company purchased in August 2015. Each share of Series B Preferred Stock is convertible into five hundred (500) shares of common stock. On March 8, 2016, the Company, through its wholly-owned subsidiary, Medical Laser Manufacturer, Inc., memorialized in a Product and Know-How License Agreement (the “License Agreement”) with Medical Lasers Manufacturer, Inc., a Florida corporation doing business as Laser Lab Corp. (“Laser Lab”), an agreement to license the use of various intellectual property in connection with seeking regulatory approval for and marketing, distributing and selling The Time Machine Series Lasers (the “TTM Series”). In connection with the Company’s agreement with Laser Lab, which agreement was memorialized in the License Agreement, on September 24, 2015, the Company filed with the Secretary of State of the State of Nevada a Certificate of Designation of Rights, Preferences and Privileges (the “Certificate of Designation”), of the Company’s Series B Convertible Preferred Stock (“Series B Preferred”). Pursuant to the Certificate of Designation, the Company designated 50,000 shares of Series B Preferred. The Series B Preferred do not hold any rights to receive dividends or any rights to vote. The Company, at its sole discretion, may redeem at any time, in whole or in part, outstanding shares of Series B Preferred for a price per share equal to the consideration paid or deemed to have been paid for such shares. The Series B Preferred may be converted, sixty days after their respective issuance, each share into the Company’s common stock at a conversion ratio equal to one (1) share of Series B Preferred for five hundred (500) shares of Common Stock. Pursuant to the License Agreement, the Company agreed to issue to Laser Lab 25,000 shares of Series B Preferred and a promissory note (the “Promissory Note”) in principal amount of $150,000 and bearing interest at 10% per annum. The principal and interest due under the Promissory Note is payable 18-months from the date of issuance. In the event, the Company does not receive, by December 31, 2016, a decision letter from the Food and Drug Administration informing the Company of the “cleared” 510(k), then the amount of 10,000 shares of Series B Preferred will be clawed back and forfeited by Laser Lab and the principal amount of the Promissory Note will automatically reduce to $75,000, as if originally issued in such denomination. Subsequent to December 31, 2015, the Company issued 4,787,129 shares of common stock upon conversion of an aggregate of $10,258 of promissory notes of the Company.

Nature of Operations and Summ22

Nature of Operations and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
Organization	Organization Medifirst Solutions, Inc. ("MSI" or the "Company") was incorporated in Nevada in November 2010. The Company has not generated significant sales to date. The Company intends to have a diverse product line of consumer products. Since inception, the Company has been engaged in business planning activities, including researching the industry, identifying target markets for the Company's products, developing the Company's models and financial forecasts, performing due diligence regarding potential geographic locations most suitable for establishing the Company's offices and identifying future sources of capital. At the present time, the Company is building products and affiliations in and related to the cosmetic healthcare industry. Pursuant to a sale and purchase agreement dated August 19, 2015 between the Company and the Company's president, the Company acquired 100% of the equity interests in Medical Lasers Manufacturer, Inc. ("MLM") with the total purchase price of 20,000 shares of the Company's common stock at $0.001 per share (or $20). The fair value of the acquired entity was $20. The transaction was considered as a business acquisition and accordingly the acquisition method of accounting has been applied. MLM had no assets at the date of the business combination. The Consolidated financial statements include the accounts of MSI and its only wholly owned subsidiary, MLM. All material intercompany balances and transactions have been eliminated in consolidation. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology.
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal recurring nature. The Company has adopted Accounting Standards Update 2014-10, Development Stage Entities (Topic 915), Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation.
Revenue Recognition	Revenue Recognition In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company's historical return experience. Revenue is presented net of returns.
Accounts Receivable	Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management's estimate of the amount of receivables that will actually be collected.
Inventory	Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value.
Equipment	Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years.
Long-Lived Assets	Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset. In August 2015, the Company's wholly-owned subsidiary MLM, acquired a trademark for $20,000. Due to the uncertainty of future cash flows from the trademark, management has deemed it to be impaired and recorded an impairment expense of $20,000 in September 2015.
Debt Issues Costs and Debt Discount	Debt Issues Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed. For December 31, 2015 and retroactively, the Company has early-adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See Note 7 to Consolidated Financial Statements).
Original Issue Discount	Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.
Derivative Liabilities	Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments; Statement of Financial Accounting Standard ASC 815 Accounting for Derivative Instruments and Hedging Activities; and Emerging Issues Task Force (“EITF”) Issue No. 00–19 and EITF 07–05. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Financial Instruments	Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values.
Segment Information	Segment Information The Company follows Accounting Standards Codification ("ASC") 280, "Segment Reporting". The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations.
Net Income (Loss) Per Common Share	Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses, common stock equivalents, if any, are not considered, as their effect would be anti-dilutive.
Income Taxes	Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities, and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of December 31, 2015, and does not expect this to change significantly over the next 12 months.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At December 31, 2015, the Company had $156,959 in cash equivalents.
Recent Pronouncements	Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company for the fiscal year beginning June 1, 2017. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. "On January 05, 2016, the FASB completed its Classification and Measurement of Financial Instruments project by issuing ASU No. 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance improves certain aspects of recognition, measurement, presentation and disclosure of financial instruments. For public business entities, the new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. " In November 2015, FASB issued ASU 2015-17 - Income Taxes (Topic 740) Balance Sheet Classification of Deferred Taxes which simplifies the presentation of deferred income taxes. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In February 2015, FASB issued ASU 2015-02 Consolidation (Topic 810) Amendments to the Consolidation Analysis. The amendments in this Update affect reporting entities that are required to evaluate whether they should consolidate certain legal entities. All legal entities are subject to reevaluation under the revised consolidation model. The amendments in this Update are effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material.

Property, Plant and Equipment23

Property, Plant and Equipment (Net)(Tables)	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment (Net) [Abstract]
Summary of equipment recorded at cost	December 31, 2015 2014 Computer equipment $ 8,314 $ 8,314 Less: accumulated depreciation (6,155 ) (4,492 ) $ 2,159 $ 3,822

6% Convertible Notes Payable (T

6% Convertible Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2015
Converted note 110 [Member]
Short-term Debt [Line Items]
Summary of convertible note conversion detail	Principal Amount Conversion Shares Date of Conversion Converted Rate Received June 2013 $ 70 $ 0.0001 700,000 August 2013 $ 40 $ 0.0001 400,000
Converted note additional 90 [Member]
Short-term Debt [Line Items]
Summary of convertible note conversion detail	Date of Conversion Principal Amount Converted Conversion Rate Shares Received November 2013 $ 40 $ 0.0001 400,000 December 2013 $ 50 $ 0.0001 500,000
Converted note 1,010 [Member]
Short-term Debt [Line Items]
Summary of convertible note conversion detail	Date of Conversion Principal Amount Converted Conversion Rate Shares Received March 2014 $ 50 $ 0.0001 500,000 April 2014 $ 40 $ 0.0001 400,000
Converted note additional 90 one [Member]
Short-term Debt [Line Items]
Summary of convertible note conversion detail	Date of Conversion Principal Amount Converted Conversion Rate Shares Received December 2012 $ 150 $ 0.001 $ 150,000 January 2013 $ 660 $ 0.001 $ 660,000 March 2013 $ 200 $ 0.001 $ 200,000

5% Convertible Notes Payables (

5% Convertible Notes Payables (Tables)	12 Months Ended
	Dec. 31, 2015
5% CONVERTIBLE NOTES PAYABLE
Short-term Debt [Line Items]
Schedule of derivative liabilities	Total Original Deferred Convertible Face Issue Derivative Financing Notes Derivative Debt Amount Discount Discount Costs Payable Liability Note Payable - BS $ 125 $ 125 Note Payable - SF 60 60 Note Payable - MC #1 2,075 2,075 Note Payable - NW 3,715 3,715 Note Payable - MC #2 3,000 3,000 Debenture Payable (5%) - B 100,000 100,000 35,176 Convertible Note Payable - CB (5%) 35,000 (3,945 ) (789 ) 30,266 Convertible Note Payable - LGC (8%) 31,000 (1,155 ) (26,314 ) (3,657 ) (126 ) 56,366 Convertible Notes Payable- VV (8%) #1 59,000 (52,321 ) (1,729 ) 4,950 66,075 Convertible Notes Payable- VV (8%) #2 38,000 (1,673 ) 36,327 $ 271,975 $ (5,100 ) $ (78,635 ) $ (7,847 ) $ 180,393 $ 157,617

Derivatives and Fair Value In26

Derivatives and Fair Value Instruments (Tables)	12 Months Ended
	Dec. 31, 2015
Derivatives and Fair Value Instruments [Abstract]
Projected annual volatility for each valuation period	10/8/2015 154 % 12/9/2015 153 % 12/22/2015 152 % 12/31/2015 151 %
Summary of convertible notes payable	Note Derivitive Treatment Date Maturity Date Principal Note Amount Original Mark to Market Derivative Value at December 31, 2015 8 % Convertible Note Payable-issued 10/8/2015 10/8/15 10/8/16 $ 31,000 $ 58,779 $ (2,413 ) $ 56,366 5 % Convertible Note Payable-issued 6/12/15 12/9/15 12/12/15 100,000 37,827 (2,651 ) 35,176 8 % Convertible Note Payable-issued 6/25/15 12/22/15 3/30/16 59,000 56,956 9,119 66,075 $ 190,000 $ 153,562 $ 4,055 $ 157,617

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Income Taxes [Abstract]
Schedule of deferred tax asset	December 31, 2015 December 31, 2014 Net operating loss carryforward $ 413,000 $ 268,000 Valuation allowance (413,000 ) (268,000 ) Deferred tax asset, net $ - $ -
Schedule of reconciliation of income tax rate	December 31, 2015 December 31, 2014 Statutory federal income tax rate 34 % 34 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (43 )% (43 )% Effective income tax rate 0 % 0 %

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2015
Related Party Transactions [Abstract]
Summary of owed amounts to related parties	2015 2014 Due to Related Party $ 8,921 $ 5,937 Due to Officer/Stockholder 20,898 33,210 Due to other Stockholders 3,550 9,000 Total Related Party Obligations $ 33,369 $ 48,147

Nature of Operations and Summ29

Nature of Operations and Summary of Significant Accounting Policies (Details)	1 Months Ended		12 Months Ended
	Sep. 30, 2015USD ($)	Aug. 31, 2015USD ($)	Dec. 31, 2015USD ($)Segment	Dec. 31, 2014USD ($)	Aug. 19, 2015USD ($)$ / shares	Dec. 31, 2013USD ($)
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Number of operating Segment | Segment			1
Cash equivalents			$ 156,958	$ 551		$ 3,720
Estimated useful lives of the assets			Five years
Impairment of trademark		$ 20,000	$ 20,000
Impairment expense	$ 20,000
Equity method investment, ownership percentage					100.00%
Total purchase price					$ 20,000
Total purchase price, Per share | $ / shares					$ 0.001

Property, Plant and Equipment30

Property, Plant and Equipment (Net) (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Computer equipment	$ 8,314	$ 8,314
Less: accumulated depreciation	(3,638)	(4,492)
Property, plant and equipment, net	$ 2,159	$ 3,822

Property, Plant and Equipment31

Property, Plant and Equipment (Net) (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Property Plant and Equipment (Net) (Textual)
Depreciation expense	$ 1,663	$ 3,933

Due to Related Party (Details)

Due to Related Party (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Due to Related Party (Textual)
Due to related party	$ 8,921	$ 5,937

Loans Payable - Stockholders (D

Loans Payable - Stockholders (Details) - USD ($)	1 Months Ended	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2015	Dec. 31, 2014
Loans payable stockholders (Textual)
Loans payable - stockholders		$ 20,899	$ 42,210
Shareholders advance		39,355	31,665
Shareholder indebted amount		$ 1,950	5,000
Interest rate on loan		20.00%
Maturity date		Jul. 2, 2012
Loan balance		$ 100	4,000
Majority Shareholder [Member]
Loans payable stockholders (Textual)
Shareholder indebted amount		$ 1,500	1,500
Interest rate on loan		26.70%
Maturity date		Jan. 1, 2014
Conversion Rate		$ 0.0001
Promissory Note [Member]
Loans payable stockholders (Textual)
Shareholder indebted amount	$ 5,000
Interest rate on loan	10.00%
Maturity date	Jun. 2, 2013
Principal amount converted		$ 2,400	$ 2,500
Shares issued on conversion of convertible notes		2,400,000	2,500,000

6% Convertible Notes Payable (D

6% Convertible Notes Payable (Details) - Converted note 110 [Member]	12 Months Ended
	Dec. 31, 2015USD ($)$ / sharesshares
June 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 70
Conversion Rate | $ / shares	$ 0.0001
Shares Received | shares	700,000
August 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 40
Conversion Rate | $ / shares	$ 0.0001
Shares Received | shares	400,000

6% Convertible Notes Payable 35

6% Convertible Notes Payable (Details 1) - Converted note additional 90 [Member]	12 Months Ended
	Dec. 31, 2015USD ($)$ / sharesshares
November 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 40
Conversion rate | $ / shares	$ 0.0001
Shares Received | shares	400,000
December 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 50
Conversion rate | $ / shares	$ 0.0001
Shares Received | shares	500,000

6% Convertible Notes Payable 36

6% Convertible Notes Payable (Details 2) - Converted note additional 90 one [Member]	12 Months Ended
	Dec. 31, 2015USD ($)$ / sharesshares
March 2014 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 50
Conversion rate | $ / shares	$ 0.0001
Shares Received | shares	500,000
April 2014 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 40
Conversion rate | $ / shares	$ 0.0001
Shares Received | shares	400,000

6% Convertible Notes Payable 37

6% Convertible Notes Payable (Details 3) - Converted note 1,010 [Member]	12 Months Ended
	Dec. 31, 2015USD ($)$ / sharesshares
December 2012 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 150
Conversion Rate | $ / shares	$ 0.001
Shares Received | shares	150,000
January 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 660
Conversion Rate | $ / shares	$ 0.001
Shares Received | shares	660,000
March 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 200
Conversion Rate | $ / shares	$ 0.001
Shares Received | shares	200,000

6% Convertible Notes Payable 38

6% Convertible Notes Payable (Details Textual) - USD ($)

Jun. 30, 2014

Apr. 30, 2015

Oct. 31, 2014

Mar. 31, 2014

Nov. 30, 2013

Oct. 31, 2013

Sep. 30, 2013

Aug. 31, 2013

Jul. 31, 2013

May. 31, 2012

Mar. 31, 2011

Apr. 30, 2014

Dec. 31, 2013

Dec. 31, 2015

Sep. 30, 2015

Dec. 31, 2014

Convertible Notes Payable (Textual)

Convertible notes, principal amount

$ 190,000

Principal amount transferred to Shareholders/Third party

$ 330

Amount of accrued interest transfered

$ 55

Interest rate on notes

20.00%

6% Convertible Notes Payable [Member]

Convertible Notes Payable (Textual)

Convertible notes, principal amount

$ 800

Maturity of convertible notes

January 2,012

Interest rate on notes

6.00%

Converted note 110 [Member]

Convertible Notes Payable (Textual)

Shares issued on conversion of convertible notes

1,000,000

50,000

1,100,000

Principal amount converted

$ 100

$ 5

$ 110

Converted note 110 [Member] | Third Party [Member]

Convertible Notes Payable (Textual)

Shares issued on conversion of convertible notes

350,000

Principal amount converted

$ 35

Converted note additional 90 [Member]

Convertible Notes Payable (Textual)

Shares issued on conversion of convertible notes

900,000

900,000

900,000

900,000

Principal amount converted

$ 90

$ 90

$ 90

$ 90

Remaining principal of note

125

Description of conversion of convertible notes

The holder of the note has the right to convert the principal into shares of the Company's common stock at any time 180 days after the closing date at $0.0001 per share.

$240 Note [Member]

Convertible Notes Payable (Textual)

Conversion rate

$ 0.0006

Shares issued on conversion of convertible notes

400,000

Principal amount converted

$ 240

Remaining principal of note

$ 60

$ 60

Description of conversion of convertible notes

The notes plus any accrued but unpaid interest are convertible at the rate of $0.0001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 3,506,665 shares at December 31, 2015.

$25,000 Note [Member]

Convertible Notes Payable (Textual)

Convertible notes, principal amount

$ 25,000

Maturity of convertible notes

November 2,012

Note conversion, maximum shares issuable in percentage of issued and outstanding common stock

9.99%

Retired amount of notes

$ 14,000

Interest rate on notes

6.00%

Conversion rate

$ 0.001

Shares issued on conversion of convertible notes

1,010,000

Principal amount converted

$ 1,010

Description of conversion of convertible notes

The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock.

$300 Note [Member]

Convertible Notes Payable (Textual)

Shares issued on conversion of convertible notes

300,000

Principal amount converted

$ 4,475

$ 300

Remaining principal of note

$ 9,690

$400 Note [Member]

Convertible Notes Payable (Textual)

Note conversion, maximum shares issuable in percentage of issued and outstanding common stock

9.99%

Interest rate on notes

3,506,665

Conversion rate

$ 0.001

$ 0.001

Shares issued on conversion of convertible notes

400,000

Principal amount converted

$ 400

$700 Note [Member]

Convertible Notes Payable (Textual)

Note conversion, maximum shares issuable in percentage of issued and outstanding common stock

9.99%

Interest rate on notes

3,506,665

Principal amount transferred to Shareholders/Third party

$ 1,000

Conversion rate

$ 0.001

$ 0.001

Shares issued on conversion of convertible notes

700,000

700,000

Principal amount converted

$ 700

$ 700

Remaining principal of note

$ 2,075

Description of conversion of convertible notes

The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 3,506,665 shares at December 31, 2015.

$1,100 Note [Member]

Convertible Notes Payable (Textual)

Note conversion, maximum shares issuable in percentage of issued and outstanding common stock

9.99%

Interest rate on notes

3,506,665

Conversion rate

$ 0.001

Shares issued on conversion of convertible notes

1,100,000

Principal amount converted

$ 1,100

Remaining principal of note

$ 3,715

$3,000 Note [Member]

Convertible Notes Payable (Textual)

Convertible notes, principal amount

$ 3,000

Maturity of convertible notes

October 2,015

Interest rate on notes

8.00%

Conversion rate

$ 0.0001

8% Convertible Note Payable (De

8% Convertible Note Payable (Details) - USD ($)	Oct. 08, 2015	Aug. 31, 2015	Jul. 31, 2015	Dec. 31, 2015
8% Convertible notes payable (Textual)
Convertible notes, principal amount				$ 190,000
Interest rate on notes				20.00%
Maturity date				Jul. 2, 2012
8% Convertible Notes Payable [Member]
8% Convertible notes payable (Textual)
Convertible notes, principal amount	$ 31,000	$ 38,000	$ 59,000
Interest rate on notes	8.00%	8.00%	8.00%
Maturity date	Oct. 8, 2016	Mar. 31, 2016	Mar. 31, 2016
Conversion date, description	The note holder has has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date.	Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outstanding principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.	Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outstanding principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.

5% Convertible Notes Payables40

5% Convertible Notes Payables (Details) - USD ($)	Dec. 31, 2015	Oct. 15, 2015	Jun. 30, 2015	Dec. 31, 2014
Short-term Debt [Line Items]
Face Amount	$ 190,000
Total Convertible Notes Payable	180,393			$ 5,975
Derivative Liabilities	157,617
5% CONVERTIBLE NOTES PAYABLE
Short-term Debt [Line Items]
Face Amount	271,975	$ 35,000	$ 100,000
Original Issue Discount	(5,100)
Derivative Discount	(78,635)
Deferred Financing Costs	(7,847)
Total Convertible Notes Payable	180,393
Derivative Liabilities	157,617
5% CONVERTIBLE NOTES PAYABLE | Note Payable - BS [Member]
Short-term Debt [Line Items]
Face Amount	$ 125
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 125
Derivative Liabilities
5% CONVERTIBLE NOTES PAYABLE | Note Payable - SF [Member]
Short-term Debt [Line Items]
Face Amount	$ 60
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 60
Derivative Liabilities
5% CONVERTIBLE NOTES PAYABLE | Note Payable - MC #1 [Member]
Short-term Debt [Line Items]
Face Amount	$ 2,075
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 2,075
Derivative Liabilities
5% CONVERTIBLE NOTES PAYABLE | Note Payable - NW [Member]
Short-term Debt [Line Items]
Face Amount	$ 3,715
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 3,715
Derivative Liabilities
5% CONVERTIBLE NOTES PAYABLE | Note Payable - MC #2 [Member]
Short-term Debt [Line Items]
Face Amount	$ 3,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 3,000
Derivative Liabilities
5% CONVERTIBLE NOTES PAYABLE | Debenture Payable (5%) - B
Short-term Debt [Line Items]
Face Amount	$ 100,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 100,000
Derivative Liabilities	35,176
5% CONVERTIBLE NOTES PAYABLE | Convertible Note Payable - CB (5%) [Member]
Short-term Debt [Line Items]
Face Amount	35,000
Original Issue Discount	$ (3,945)
Derivative Discount
Deferred Financing Costs	$ (789)
Total Convertible Notes Payable	$ 30,266
Derivative Liabilities
5% CONVERTIBLE NOTES PAYABLE | Convertible Note Payable - LGC (8%) [Member]
Short-term Debt [Line Items]
Face Amount	$ 31,000
Original Issue Discount	(1,155)
Derivative Discount	(26,314)
Deferred Financing Costs	(3,657)
Total Convertible Notes Payable	(126)
Derivative Liabilities	56,366
5% CONVERTIBLE NOTES PAYABLE | Convertible Notes Payable- VV (8%) #1 [Member]
Short-term Debt [Line Items]
Face Amount	$ 59,000
Original Issue Discount
Derivative Discount	$ (52,321)
Deferred Financing Costs	(1,729)
Total Convertible Notes Payable	4,950
Derivative Liabilities	66,075
5% CONVERTIBLE NOTES PAYABLE | Convertible Notes Payable- VV (8%) #2 [Member]
Short-term Debt [Line Items]
Face Amount	$ 38,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs	$ (1,673)
Total Convertible Notes Payable	$ 36,327
Derivative Liabilities

5% Convertible Notes Payables41

5% Convertible Notes Payables (Details Textual) - USD ($)	Oct. 15, 2015	Jun. 30, 2015	Dec. 31, 2015
5% Convertible notes payable (Textual)
Convertible notes, principal amount			$ 190,000
Interest rate on notes			20.00%
Maturity date			Jul. 2, 2012
5% CONVERTIBLE NOTES PAYABLE
5% Convertible notes payable (Textual)
Convertible notes, principal amount	$ 35,000	$ 100,000	$ 271,975
Interest rate on notes	5.00%	5.00%
Maturity date	Oct. 15, 2016	Dec. 31, 2015
Conversion date, description		Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date.
Original issue debt discount	$ 5,000
Debt discounted rate, Percentage	55.00%
Convertible notes payable converted into common stock			86,385,000

Derivatives and Fair Value In42

Derivatives and Fair Value Instruments (Details)	12 Months Ended
	Dec. 31, 2015
10/8/2015 [Member]
Projected annual volatility for each valuation period
Volatility rate	154.00%
12/9/2015 [Member]
Projected annual volatility for each valuation period
Volatility rate	153.00%
12/22/2015 [Member]
Projected annual volatility for each valuation period
Volatility rate	152.00%
12/31/2015 [Member]
Projected annual volatility for each valuation period
Volatility rate	151.00%

Derivatives and Fair Value In43

Derivatives and Fair Value Instruments (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Summary of convertible notes payable
Principal Note Amount	$ 190,000
Original Derivitive Valuation	153,562
Market to Market	4,055
Derivative Value	$ 157,617
8 % Convertible Note Payable-issued 10/8/2015 [Member]
Summary of convertible notes payable
Derivitive Treatment Date	Oct. 8, 2015
Maturity Date	Oct. 8, 2016
Original Derivitive Valuation	$ 58,779
Market to Market	$ (2,413)
5 % Convertible Note Payable-issued 6/12/15 [Member]
Summary of convertible notes payable
Derivitive Treatment Date	Dec. 9, 2015
Maturity Date	Dec. 12, 2015
Original Derivitive Valuation	$ 37,827
Market to Market	$ (2,651)
8 % Convertible Note Payable-issued 6/25/15 [Member]
Summary of convertible notes payable
Derivitive Treatment Date	Dec. 22, 2015
Maturity Date	Mar. 30, 2016
Original Derivitive Valuation	$ 56,956
Market to Market	$ 9,119

Derivatives and Fair Value In44

Derivatives and Fair Value Instruments (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Jun. 25, 2015	Jun. 12, 2015
Derivatives and Fair Value Instruments (Textual)
Debt Instrument, Interest Rate, Stated Percentage	20.00%
Derivative, description	- An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%;- Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%;
Monthly trading volume	$ 258,000
Maximum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	153.30%
Stock price	$ 0.010
Variable conversion rate	55.00%
Derivatives trading preiod	10 days
Derivatives effective rate	51.14%
Minimum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	151.40%
Stock price	$ 0.0073
Variable conversion rate	50.00%
Derivatives trading preiod	3 days
Derivatives effective rate	44.12%
5 % Convertible Note Payable-issued 6/12/15 [Member]
Derivatives and Fair Value Instruments (Textual)
Debt Instrument, Interest Rate, Stated Percentage			5.00%
8 % Convertible Note Payable-issued 6/25/15 [Member]
Derivatives and Fair Value Instruments (Textual)
Debt Instrument, Interest Rate, Stated Percentage		8.00%

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Stockholders Equity (Textual)
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares outstanding	35,101,750	22,481,750
Common stock, shares issued	35,101,750	22,481,750
Issuance of common shares to investor	$ 20
Convertible preferred stock description	The Series B preferred stock has no voting rights. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock.
Common Stock [Member]
Stockholders Equity (Textual)
Common stock issued for services		1,000,000
Issuance of common shares to investor	$ 20
Issuance of shares to investor, Share price	$ 0.01
March 31, 2015 [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.0001
Common stock, shares issued	2,000,000
Cancellation of common shares to recapitalize company (Shares)	500,000
March 31, 2015 One [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.0005
Common stock, shares issued	800,000
June 30, 2015 [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.0005
Common stock, shares issued	2,300,000
September 30, 2015 [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.0005
Common stock, shares issued	3,800,000
September 30, 2015 one [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.01
Common stock shares issued for acquisition	20,000
Price per share	$ 0.015
Percentage of aquisition	100.00%
Common stock issued for services	50,000
Officers Compensation [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.01
Common stock issued for officers compensation	3,000,000
December 31, 2015 [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.01
Common stock, shares issued	500,000
Series A preferred stock [Member]
Stockholders Equity (Textual)
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	50,000	50,000
Preferred stock, shares outstanding	50,000	50,000
Common stock issued for services	100
Series B Preferred Stock [Member]
Stockholders Equity (Textual)
Preferred stock, shares authorized	50,000	50,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Commitments and contingencies (Texual)
Current office space rate per month	$ 525
Rent expense	$ 6,500	$ 5,274

Income Taxes (Details )

Income Taxes (Details ) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Income Taxes [Abstract]
Net operating loss carryforward	$ 413,000	$ 268,000
Valuation allowance	$ (413,000)	$ (268,000)
Deferred tax asset, net

Income Taxes (Details 1)

Income Taxes (Details 1)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Reconciliation of income tax rate
Statutory federal income tax rate	34.00%	34.00%
State income taxes, net of federal taxes	9.00%	9.00%
Valuation allowance	(43.00%)	(43.00%)
Effective income tax rate	0.00%	0.00%

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Taxes (Textual)
Net operating loss carryforward	$ 413,000	$ 268,000
Operating loss carryforwards expiration period, description	Reduce future federal and state taxable income through 2035.
Income taxes	$ 550	$ 800

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Owed amount of related parties
Due to related party	$ 8,921	$ 5,937
Due to Officer/Stockholder	20,898	33,210
Due to other Stockholders	3,550	9,000
Total Related Party Obligations	$ 33,369	$ 48,147

Related Party Transactions (D51

Related Party Transactions (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	Aug. 31, 2015	Dec. 31, 2015	Dec. 31, 2014	Aug. 19, 2015	May. 31, 2014
Related Party Transaction [Line Items]
Fair value of acquired entity				$ 20,000
Impairment of Trademark	$ 20,000	$ 20,000
Voting right per share					$ 2,000
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Base compensation		$ 100,000	$ 100,000
Series A preferred stock, Shares					50,000
Medical Lasers Manufacturer, Inc. [Member]
Related Party Transaction [Line Items]
Percentage of aquisition	100.00%
Common stock shares issued for acquisition	20,000
Price per share	$ 0.015
Fair value of acquired entity	$ 20,000
Purchase of inventory	$ 50,000
Acquisition of MLM, description	MLM acquired a trademark from the son of the Company's President for $20,000 due 90 days from the date of acquisition.

Basis of Reporting - Going Co52

Basis of Reporting - Going Concern (Details)	12 Months Ended
	Dec. 31, 2015USD ($)
Basis of Reporting (Textual)
Net losses	$ 964,000

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Mar. 08, 2016	Jan. 13, 2016	Jan. 07, 2016	Feb. 29, 2016	Jan. 31, 2016	Aug. 31, 2015	Dec. 31, 2015	Jun. 15, 2016	Mar. 15, 2016	Dec. 31, 2014
Subsequent Events (Textual)
Promissory note							$ 100			$ 4,000
Maturity date							Jul. 2, 2012
Aggregate value of common stock upon conversion							$ 10,258
Shares of common stock upon conversion							4,787,129
Series B Preferred Stock [Member]
Subsequent Events (Textual)
Shares exchanged						10,000
Convertible stock, description						The conversion of 3,400 shares of Series B Preferred Stock was a partial conversion of the 10,000 shares of the Series B Preferred Stock it issued in satisfaction of the obligation to issue such shares to the seller of $50,000 of inventory the Company purchased in August 2015. Each share of Series B Preferred Stock is convertible into five hundred (500) shares of common stock.
Subsequent Event [Member]
Subsequent Events (Textual)
Ner proceeds from issuance		$ 75,696.69
Investor note, description		In consideration for the issuance of the $50K Note, the Investor issued to the Company a $50,000 fully-collateralized secured promissory note (the "Investor Note"), pursuant to which the Investor agreed to pay the Company $50,000 on or before April 30, 2016.
Interest rate terms		Bear interest at the rate of 8% per annum.
Subsequent Event [Member] | Common Stock [Member]
Subsequent Events (Textual)
Shares exchanged				1,700,000
Subsequent Event [Member] | Series B Preferred Stock [Member]
Subsequent Events (Textual)
Shares exchanged				3,400
Description of conversion of convertible notes	The Series B Preferred may be converted, sixty days after their respective issuance, each share into the Company's common stock at a conversion ratio equal to one (1) share of Series B Preferred for five hundred (500) shares of Common Stock.
Subsequent Event [Member] | Series B Preferred Stock [Member] | Medical Lasers Manufacturer, Inc. [Member]
Subsequent Events (Textual)
Number of designated shares of Series B Preferred	50,000
Subsequent Event [Member] | Convertible redeemable [Member]
Subsequent Events (Textual)
Principal amount converted			$ 61,508.71	$ 39,557.4
Promissory note			$ 59,000	$ 38,000
Maturity date			Jan. 7, 2017	Feb. 28, 2017
convertible redeemable replacement note, Description			The $61,508.71 principal amount of the $61K Replacement Note reflected the principal and accrued interest under the $61K Original Note. The $61K Replacement Note, which is due on January 7, 2017, may not be prepaid but otherwise contains identical provisions to that of the Notes.	The $39,557.48 principal amount of the Replacement Note reflected the principal and accrued interest under the Original Note. The Replacement Note, which is due on February 28, 2017, may not be prepaid but otherwise contains identical provisions to that of the Notes.
Subsequent Event [Member] | Securities Purchase Agreement [Member]
Subsequent Events (Textual)
Principal amount converted					$ 251,803
Sale and purchase original principle amount								$ 46,803	$ 50,000
Subsequent Event [Member] | License Agreement [Member] | Series B Preferred Stock [Member] | Medical Lasers Manufacturer, Inc. [Member]
Subsequent Events (Textual)
Principal amount converted	$ 150,000
Convertible stock, description	The principal and interest due under the Promissory Note is payable 18-months from the date of issuance. In the event, the Company does not receive, by December 31, 2016, a decision letter from the Food and Drug Administration informing the Company of the "cleared" 510(k), then the amount of 10,000 shares of Series B Preferred will be clawed back and forfeited by Laser Lab and the principal amount of the Promissory Note will automatically reduce to $75,000, as if originally issued in such denomination.
Interest rate terms	Bearing interest at 10% per annum.
Convertible Debt [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member]
Subsequent Events (Textual)
Principal amount converted			$ 105,000
Issuance discount			20,000
Convertible stock, description		Subject to a beneficial ownership limitation equal to 9.99%, principal and interest on all the notes issued pursuant to the Purchase Agreement convertible into shares of the Company's common stock at a conversion price equal to 55% of the lowest trading price of Common Stock during the 20 trading day period prior to conversion.
Convertible Debt One [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member]
Subsequent Events (Textual)
Principal amount converted			$ 50,000